Evaluation of Zinc in urinary tract infection

Evaluation of zinc supplementation with treatment of children with urinary tract infection

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181023041439N1

Enrollment

Registered

2018-12-16

Start date

2018-03-21

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary infection. Urinary tract infection, site not specified

Interventions

Intervention 1: "Intervention group": 26 of 3 to12 years old child from both girl and boy affected to clinical urinary infection hospitalized in the zanjan ayatollah mosavi hospital in1397 that have

Eligibility

Sex/Gender

All

Age

3 Years to 12 Years

Inclusion criteria

Inclusion criteria: 3 to12 years old Urinary tract infection(Pyelonephritis)

Exclusion criteria

Exclusion criteria: Change in treatment Personal satisfaction Incorrect use of drug

Design outcomes

Primary

Measure	Time frame
Percent ofChildrene with urinary tract infection (Positive urine culture). Timepoint: Evaluation of urine culture after48 hour and 14day after bigining of zinc. Method of measurement: Urine analysis and urine culture.	—

Secondary

Measure	Time frame
"End of fever". Timepoint: "During hospitilization". Method of measurement: "Questionnaire".;"Dysuria". Timepoint: "During hospitilization". Method of measurement: "Questionnaire".;"Stomach pain". Timepoint: "During hospitilization". Method of measurement: "Qustonnaire".;"Duration of hispitilization". Timepoint: "During hospitilization". Method of measurement: "Queationnaire".	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNahideh Bizhan

Zanjan University of Medical Sciences

2nb1365@zums.ac.ir+98 24 3344 0300

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026